1. Home
  2. SMID vs TTRX Comparison

SMID vs TTRX Comparison

Compare SMID & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith-Midland Corporation

SMID

Smith-Midland Corporation

HOLD

Current Price

$29.25

Market Cap

157.6M

Sector

Industrials

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$7.69

Market Cap

281.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMID
TTRX
Founded
1960
2015
Country
United States
United States
Employees
N/A
2
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.6M
281.2M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
SMID
TTRX
Price
$29.25
$7.69
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
11.3K
125.6K
Earning Date
04-14-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
62.76
N/A
EPS
0.25
N/A
Revenue
$93,446,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$123.76
N/A
Revenue Growth
19.03
N/A
52 Week Low
$25.60
$2.57
52 Week High
$43.62
$11.69

Technical Indicators

Market Signals
Indicator
SMID
TTRX
Relative Strength Index (RSI) 48.91 46.44
Support Level $28.01 $4.40
Resistance Level $31.21 $10.48
Average True Range (ATR) 1.16 0.89
MACD 0.15 -0.30
Stochastic Oscillator 39.54 3.62

Price Performance

Historical Comparison
SMID
TTRX

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: